台股 » 個股 » 易威 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

易威

(1799)
  • 股價
    70.1
  • 漲跌
    ▼0.2
  • 漲幅
    -0.28%
  • 成交量
    109
  • 產業
    上櫃 生技醫療類股
  • 65人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
易威 (1799)籌碼相關-群益金鼎-松山 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

群益金鼎-松山 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/04/2300.00365.0068.00-3256-1.17%
2024/01/0200.001341.3040.80-13240-5.41%
2023/12/011341.1000.0040.00132106.18%
2021/12/2000.002916.6016.60-29114-25.41%
2021/12/172916.4800.0016.202911126.07%
2021/11/2900.001016.5017.00-10101-9.90%
2021/08/06515.9500.0016.0052911.72%
2021/07/221015.7000.0015.70103862.58%
2021/02/2200.003116.5017.60-31176-17.55%
2021/02/193115.4000.0016.003117118.10%
2020/10/23220.0000.0019.7025480.36%
2020/09/2200.00218.2018.20-21,342-0.15%
2020/09/2100.005118.9218.75-511,350-3.78%
2020/09/185318.9600.0018.90531,3563.91%
2020/09/1600.006818.7718.55-681,367-4.97%
2020/09/156819.1200.0019.15681,3774.94%
2020/08/24120.5500.0020.8011,9820.05%
2020/08/20119.7000.0019.7012,1210.05%
2020/07/23229.0000.0028.8022,2330.09%
2020/07/1400.00529.6529.60-51,907-0.26%
2020/07/13531.55530.7331.5501,7930.00%
2020/07/10528.7000.0028.7051,6660.30%
2020/07/0700.002222.1321.60-221,505-1.46%
2020/07/0300.003822.9024.20-381,434-2.65%
2020/07/023024.8500.0024.70301,4282.10%
2020/07/013024.003023.7024.0001,4200.00%
2020/06/303023.173022.7223.4501,4160.00%
2020/06/293022.3000.0022.30301,4062.13%
2020/06/1900.003022.9022.20-301,393-2.15%
2020/06/183022.9000.0022.85301,3722.19%
2020/06/1500.003122.8024.20-311,207-2.57%
2020/06/123019.0000.0022.00301,1242.67%
2020/06/1000.002018.1719.10-20985-2.03%
2020/06/092017.404017.6817.40-20958-2.09%
2020/06/084017.6100.0018.00409464.22%
2020/06/0400.001017.7017.00-10955-1.05%
2020/06/031017.1000.0017.60109631.04%
2020/06/0100.002018.7017.70-20968-2.06%
2020/05/292018.603018.2218.50-10973-1.03%
2020/05/283117.822017.8018.50119781.12%
2020/05/222017.2700.0017.90209302.15%
2020/05/0600.002312.9012.65-23761-3.02%
2020/05/052312.402012.9812.4037420.40%
2020/05/042012.4000.0012.40207242.76%
2019/12/1800.002010.1510.10-2066-30.04%
2019/08/29209.9000.009.992014813.48%
2018/12/2700.001511.1311.10-1562-23.85%
2018/12/261511.3700.0011.15156223.90%
2018/09/2700.001016.8116.60-10116-8.59%
2018/09/261017.0000.0016.85101178.52%
2018/09/2000.00116.7016.70-1117-0.85%
2018/08/21117.1500.0017.2011160.86%
2018/06/2900.001317.5017.45-13401-3.24%
2018/06/281317.9200.0017.45134013.24%
2018/06/2200.00117.6017.55-1399-0.25%
2018/06/19117.9000.0017.8013980.25%
2018/05/2400.00117.9518.00-1393-0.25%
2018/05/2200.00118.1518.25-1401-0.25%
2018/05/18218.5300.0018.2523980.50%
2018/04/1600.001021.3521.35-10329-3.03%
2018/04/131024.202023.3523.70-10302-3.31%
2018/04/122022.002023.0022.0002490.00%
2018/04/112022.3500.0022.90202328.61%
2018/03/2700.001019.5519.00-10186-5.36%
2018/03/261019.5500.0019.70101875.34%
易威慢性心臟衰竭用藥獲中國藥證 明年Q1底展開銷售Anue鉅亨-2023/10/30
美新行政令強化製藥在地化 易威、泰福-KY迎來新訂單Anue鉅亨-2022/09/20
〈易威法說〉策略轉型見成效 新藥、學名藥營收比重拚達7成Anue鉅亨-2021/12/17
易威 相關文章
易威 相關影音